TF and glioblastoma: Svensson and colleagues found that TF + EVs derived from the human glioblastoma cell line U87-MG enhance the expression of pro-angiogenic, heparin-binding EGF via activation of the PAR2-ERK1/2 pathway in hypoxic human umbilical vein endothelial cells [103].